Satsuma Pharmaceuticals Q3 EPS $(2.26) Down From $(1.48) YoY

Satsuma Pharmaceuticals (NASDAQ:STSA) reported quarterly losses of $(2.26) per share. This is a 52.7 percent decrease over losses of $(1.48) per share from the same period last year.

Benzinga · 11/12/2019 21:04

Satsuma Pharmaceuticals (NASDAQ:STSA) reported quarterly losses of $(2.26) per share. This is a 52.7 percent decrease over losses of $(1.48) per share from the same period last year.